Safety of poly-L-lactic acid (New-Fill(®)) in the treatment of facial lipoatrophy: a large observational study among HIV-positive patients

BACKGROUND: Facial lipoatrophy is a frequently reported condition associated with use of antiretroviral (ARV) drugs. Poly-L-lactic acid (PLLA) acid has been used to correct facial lipoatrophy in people with HIV since 2004 both in Europe and the United States. The objective of this study was to estab...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Duracinsky, Martin, Leclercq, Pascale, Herrmann, Susan, Christen, Marie-Odile, Dolivo, Marc, Goujard, Cécile, Chassany, Olivier
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4160543/
https://ncbi.nlm.nih.gov/pubmed/25178390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-14-474
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items